Patents by Inventor Dillon Hanrahan

Dillon Hanrahan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICELLES AND VESICLES FOR THE DELIVERY OF GLYCOPEPTIDES
    Publication number: 20230104480
    Abstract: Methods for quality control and optimizing the formation and characterization of micelles, vesicles or other aggregates are described herein. Pharmaceutically relevant peptides may be modified to form glycopeptide surfactants which form micelles or other aggregates with another surfactant. Glycopeptide and glycolipid surfactants can aggregate to form particles that enhance drug delivery. The glycopeptide surfactants may be drugs or prodrugs which are delivered via the micelles or other aggregated structures.
    Type: Application
    Filed: November 21, 2022
    Publication date: April 6, 2023
    Inventors: Robin L. Polt, Dillon Hanrahan, Lajos Z. Szabo, Michael L. Heien, Chenxi Liu
  • ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY
    Publication number: 20230041342
    Abstract: The invention provides novel compounds, compositions and formulations of liposomes, microbubbles and/or nanodroplets, and emulsions thereof, that are useful in delivery of various nucleic acids and genes (e.g., single stranded RNA, DNA, si-RNA and CRISPR constructs), as well as methods of preparation and use thereof including methods of imaging and gene delivery using ultrasound activation.
    Type: Application
    Filed: January 7, 2021
    Publication date: February 9, 2023
    Inventors: Evan C. Unger, Emmanuelle Joelle Meuillet, Maria F. Acosta, Dillon Hanrahan
  • Micelles and vesicles for the delivery of glycopeptides
    Patent number: 11504325
    Abstract: Methods for quality control and optimizing the formation and characterization of micelles, vesicles or other aggregates are described herein. Pharmaceutically relevant peptides may be modified to form glycopeptide surfactants which form micelles or other aggregates with another surfactant. Glycopeptide and glycolipid surfactants can aggregate to form particles that enhance drug delivery. The glycopeptide surfactants may be drugs or pro-drugs which are delivered via the micelles or other aggregated structures.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: November 22, 2022
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Robin L. Polt, Dillon Hanrahan, Lajos Z. Szabo, Michael L. Heien, Chenxi Liu
  • MICELLES AND VESICLES FOR THE DELIVERY OF GLYCOPEPTIDES
    Publication number: 20210361572
    Abstract: Methods for quality control and optimizing the formation and characterization of micelles, vesicles or other aggregates are described herein. Pharmaceutically relevant peptides may be modified to form glycopeptide surfactants which form micelles or other aggregates with another surfactant. Glycopeptide and glycolipid surfactants can aggregate to form particles that enhance drug delivery. The glycopeptide surfactants may be drugs or pro-drugs which are delivered via the micelles or other aggregated structures.
    Type: Application
    Filed: August 9, 2018
    Publication date: November 25, 2021
    Inventors: Robin L. Polt, Dillon Hanrahan, Lajos Z. Szabo, Michael L. Heien, Chenxi Liu